ClinicalTrials.Veeva

Menu
H

Hospital de Clinicas de Passo Fundo | Clinical Research Center | Passo Fundo, Brazil

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Durvalumab
Platinum
Etoposide
Ixazomib Citrate
MEK162
Dacarbazine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 3 total trials
Locations recently updated

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab (DeLLphi-305)

The primary objective of this study is to compare the efficacy of tarlatamab plus durvalumab with durvalumab alone on prolonging overall survival (OS...

Enrolling
Small-Cell Lung Cancer
Extensive-Stage Small-Cell Lung Cancer
Drug: Tarlatamab
Drug: Durvalumab

Trial sponsors

Amgen logo
Pfizer logo
Takeda logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems